This data also suggests that Aco2 can be a potential goal in the treatment of HD and indicates that increasing the functional activity of aconitase and/or reducing the intensity of oxidative stress may be an effective component of the treatment strategy for HD. The gene discussed is ACO2; the disease is Huntington disease.